These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27007227)
1. Regulatory T Cells in Chronic Graft-Versus-Host Disease After Extracorporeal Photopheresis: Correlation With Skin and Global Organ Responses, and Ability to Taper Steroids. Denney HA; Whittle RJ; Lai J; Jacques RM; Taylor PC Transplantation; 2017 Jan; 101(1):204-211. PubMed ID: 27007227 [TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photopheresis normalizes some lymphocyte subsets (including T regulatory cells) in chronic graft-versus-host-disease. Bladon J; Taylor P Ther Apher Dial; 2008 Aug; 12(4):311-8. PubMed ID: 18789119 [TBL] [Abstract][Full Text] [Related]
3. CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy. Rubegni P; Sbano P; Cevenini G; Perari MG; Marotta G; Risulo M; Carcagnì MR; D' Ascenzo G; De Aloe G; Fimiani M Int J Immunopathol Pharmacol; 2007; 20(4):801-7. PubMed ID: 18179753 [TBL] [Abstract][Full Text] [Related]
4. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production. Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host disease. Belizaire R; Kim HT; Poryanda SJ; Mirkovic NV; Hipolito E; Savage WJ; Reynolds CG; Fields MJ; Whangbo J; Kubo T; Nikiforow S; Alyea EP; Armand P; Cutler CS; Ho VT; Blazar BR; Antin JH; Ritz J; Soiffer RJ; Koreth J Blood Adv; 2019 Apr; 3(7):969-979. PubMed ID: 30936057 [TBL] [Abstract][Full Text] [Related]
6. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389 [TBL] [Abstract][Full Text] [Related]
7. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects. Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A Front Immunol; 2018; 9():2207. PubMed ID: 30349527 [TBL] [Abstract][Full Text] [Related]
8. A Prospective Trial of Extracorporeal Photopheresis for Chronic Graft-versus-Host Disease Reveals Significant Disease Response and No Association with Frequency of Regulatory T Cells. Gandelman JS; Song DJ; Chen H; Engelhardt BG; Chen YB; Clark WB; Giver CR; Waller EK; Jung DK; Jagasia M Biol Blood Marrow Transplant; 2018 Dec; 24(12):2373-2380. PubMed ID: 29981848 [TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841 [TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form. Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380 [TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease. Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621 [TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+CD25+GITR+Foxp3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Biagi E; Di Biaso I; Leoni V; Gaipa G; Rossi V; Bugarin C; Renoldi G; Parma M; Balduzzi A; Perseghin P; Biondi A Transplantation; 2007 Jul; 84(1):31-9. PubMed ID: 17627234 [TBL] [Abstract][Full Text] [Related]
13. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis. Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598 [TBL] [Abstract][Full Text] [Related]
14. Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Meloni F; Cascina A; Miserere S; Perotti C; Vitulo P; Fietta AM Transplant Proc; 2007; 39(1):213-7. PubMed ID: 17275508 [TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology. Tsirigotis P; Kapsimalli V; Baltadakis I; Kaloyannidis P; Karakasis D; Papalexandri A; Psarra E; Nosi E; Konsta E; Vikentiou M; Papageorgiou S; Sakellari I; Pappa V; Harhalakis N; Anagnostopoulos A; Dervenoulas J Transfus Apher Sci; 2012 Apr; 46(2):181-8. PubMed ID: 22115608 [TBL] [Abstract][Full Text] [Related]
16. [Extracorporeal photopheresis in treatment of chronic graft versus host disease]. Bojanić I; Seiwerth RS; Mazić S; Dubravcić K; Batinić D; Cepulić BG; Labar B Lijec Vjesn; 2013; 135(5-6):139-44. PubMed ID: 23898694 [TBL] [Abstract][Full Text] [Related]
17. Response of steroid-refractory chronic graft-versus-host disease to extracorporeal photopheresis correlates with the dose of CD3+ lymphocytes harvested during early treatment cycles. Bertani G; Santoleri L; Ferri U; Marenco P; Grillo G; Zucchetti E; Forno B; Lando G; Scarpati B; Cairoli R; Rossini S; Cesana C Transfusion; 2016 Feb; 56(2):505-10. PubMed ID: 26453579 [TBL] [Abstract][Full Text] [Related]
18. Extracorporeal Photopheresis: An Efficacious and Well-Tolerated Treatment for Cutaneous and Oral Mucosal Chronic Graft-versus-Host Disease. Richet C; Huynh A; Dimeglio C; Borel C; Lepage B; Boulinguez S; Marguery MC; Paul C; Bulai Livideanu C Dermatology; 2018; 234(1-2):23-30. PubMed ID: 29788024 [TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis as an antirejection prophylaxis in kidney transplant recipients: preliminary results. Kusztal M; Kościelska-Kasprzak K; Gdowska W; Zabińska M; Myszka M; Kłak R; Krajewska M; Boratyńska M; Szyber P; Chudoba P; Patrzałek D; Klinger M Transplant Proc; 2011 Oct; 43(8):2938-40. PubMed ID: 21996194 [TBL] [Abstract][Full Text] [Related]
20. Receiver operating characteristic curve analysis of circulating blood dendritic cell precursors and T cells predicts response to extracorporeal photopheresis in patients with chronic graft-versus-host disease. Akhtari M; Giver CR; Ali Z; Flowers CR; Gleason CL; Hillyer CD; Kaufman J; Khoury HJ; Langston AA; Lechowicz MJ; Lonial S; Renfroe HM; Roback JD; Tighiouart M; Vaughn L; Waller EK Transfusion; 2010 Nov; 50(11):2424-31. PubMed ID: 20529004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]